Table 2 Characteristics of each categorical variable
Variables | With DGF (n = 78) | Without DGF (n = 383) |
|---|---|---|
Donor demographics | ||
 Gender, n (%) | ||
  Male | 59 (75.64) | 262 (68.41) |
  Female | 19 (24.36) | 121 (31.59) |
 Age, n (%) | ||
  Young children (≤ 12 years) | 10 (12.82) | 12 (15.38) |
  Adolescents and adults (13–59 years) | 56 (71.79) | 262 (68.41) |
  The aged (≥ 60 years) | 12 (15.38) | 67 (17.49) |
Donor clinical characteristics | ||
 Donor type, n (%) | ||
  DBD | 56 (71.79) | 318 (83.03) |
  DCD | 21 (26.92) | 54 (14.10) |
  DBCD | 1 (1.28) | 1 (0.26) |
 History of hypertension, n (%) | ||
  Yes | 28 (35.90) | 123 (32.11) |
  No | 48 (61.54) | 240 (62.66) |
  Unknown | 2 (2.56) | 20 (5.22) |
 History of diabetes, n (%) | ||
  Yes | 9 (11.54) | 38 (9.92) |
  No | 55 (70.51) | 315 (82.25) |
  Unknown | 14 (17.95) | 30 (7.83) |
 History of CPR, n (%) | ||
  Yes | 20 (25.64) | 59 (15.40) |
  No | 58 (74.36) | 324 (84.60) |
 Primary cause of death, n (%) | ||
  Head trauma | 2 (2.57) | 158 (41.25) |
  Stroke | 58 (74.36) | 161 (42.03) |
  Other | 18 (23.08) | 64 (16.71) |
 History of hypotension, n (%) | ||
  Yes | 54 (69.23) | 214 (55.87) |
  No | 24 (30.77) | 169 (44.13) |
 History of HCV, n (%) | ||
  Yes | 2 (2.56) | 4 (1.04) |
  No | 76 (97.44) | 379 (98.96) |
 LifePort, n (%) | ||
  Yes | 5 (6.41) | 4 (1.04) |
  No | 73 (93.59) | 379 (98.96) |
Recipient demographics | ||
 Gender, n (%) | ||
  Male | 59 (75.64) | 262 (68.41) |
  Female | 19 (24.36) | 121 (31.59) |
Recipient clinical characteristics | ||
 Primary disease for renal failure, n (%) | ||
  Diabetes | 3 (3.85) | 7 (1.83) |
  Hypertension | 13 (16.67) | 47 (12.27) |
  Purpura nephritis | 0 (0) | 3 (0.78) |
  Urologic obstruction | 1 (1.28) | 1 (0.26) |
  Polycystic kidney | 4 (5.13) | 6 (1.57) |
  Vasculitis | 0 (0) | 9 (2.35) |
  Other | 58 (74.36) | 313 (81.72) |
 PRA level, n (%) | ||
  Positive | 3 (3.85) | 25 (6.53) |
  Negative | 75 (96.15) | 358 (93.47) |
 Immunity Induction, n (%) | ||
  Yes | 63 (80.77) | 312 (81.46) |
  No | 15 (19.23) | 71 (18.54) |